| http://www.w3.org/ns/prov#value | - The invention also includes the use of such selective adenosine A1 receptor agonists, antagonists or allosteric enhancers in the manufacture of medicaments for the treatment of a condition or symptom in a mammalian subject, such as a human, which is associated with angiogenesis.
|
